Search research articles
Contact Us
Filters
Showing results (411-420 of 431) with videos related to
Page
of 44
Sort By:
Cell Stem Cell
|
August 3, 2019
Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia
Mark D McKenzie, Margherita Ghisi, Ethan P Oxley, et al.
Pediatrics
|
January 28, 2021
Appendectomy Versus Observation for Appendicitis in Neutropenic Children With Cancer
Benjamin T Many, Timothy B Lautz, Sarah Dobrozsi, et al.
Science (New York, N.Y.)
|
June 17, 2020
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen, Alina Baum, Kristen E Pascal, et al.
Communications Biology
|
April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
Karuna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Annals of Surgery
|
June 2, 2023
Management and Outcomes of Wilms Tumor With Suprarenal Intravascular Extension: A Pediatric Surgical Oncology Research Collaborative Study
Bindi Naik-Mathuria, Alan F Utria, Peter F Ehrlich, et al.
Cell Reports
|
March 18, 2026
Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor
Andrew M Fleming, Carolyn M Jablonowski, Hongjian Jin, et al.
International Journal of Cancer
|
May 23, 2022
Inflammatory myofibroblastic tumor: A multi-institutional study from the Pediatric Surgical Oncology Research Collaborative
Barrie S Rich, Joanna Fishbein, Timothy Lautz, et al.
Annals of Surgery
|
November 6, 2020
Implications of Tumor Characteristics and Treatment Modality on Local Recurrence and Functional Outcomes in Children With Chest Wall Sarcoma: A Pediatric Surgical Oncology Research Collaborative Study
Courtney J Harris, Irene Helenowski, Andrew J Murphy, et al.
Nature
|
September 11, 2024
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
Michael E Dunn, Aaron Kithcart, Jee Hae Kim, et al.
Science Translational Medicine
|
June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy
Janelle C Waite, Bei Wang, Lauric Haber, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 431) with videos related to
Sort By:
Page
of 44
Cell Stem Cell
|
August 3, 2019
Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia
Mark D McKenzie, Margherita Ghisi, Ethan P Oxley, et al.
Pediatrics
|
January 28, 2021
Appendectomy Versus Observation for Appendicitis in Neutropenic Children With Cancer
Benjamin T Many, Timothy B Lautz, Sarah Dobrozsi, et al.
Science (New York, N.Y.)
|
June 17, 2020
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen, Alina Baum, Kristen E Pascal, et al.
Communications Biology
|
April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
Karuna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Annals of Surgery
|
June 2, 2023
Management and Outcomes of Wilms Tumor With Suprarenal Intravascular Extension: A Pediatric Surgical Oncology Research Collaborative Study
Bindi Naik-Mathuria, Alan F Utria, Peter F Ehrlich, et al.
Cell Reports
|
March 18, 2026
Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor
Andrew M Fleming, Carolyn M Jablonowski, Hongjian Jin, et al.
International Journal of Cancer
|
May 23, 2022
Inflammatory myofibroblastic tumor: A multi-institutional study from the Pediatric Surgical Oncology Research Collaborative
Barrie S Rich, Joanna Fishbein, Timothy Lautz, et al.
Annals of Surgery
|
November 6, 2020
Implications of Tumor Characteristics and Treatment Modality on Local Recurrence and Functional Outcomes in Children With Chest Wall Sarcoma: A Pediatric Surgical Oncology Research Collaborative Study
Courtney J Harris, Irene Helenowski, Andrew J Murphy, et al.
Nature
|
September 11, 2024
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
Michael E Dunn, Aaron Kithcart, Jee Hae Kim, et al.
Science Translational Medicine
|
June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy
Janelle C Waite, Bei Wang, Lauric Haber, et al.
Page
of 44